Xi Hongqing, Li Jiyang, Li Shaoqing, Qiao Zhi, Wei Bo, Chen Lin
Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing 100853,China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):507-513.
To investigate and compare the clinicopathological characteristics of gastric stump cancer(GSC) and the recurrent of gastric cancer (RGC) following radical gastrectomy, and to evaluate survival prognosis.
A retrospective cohort study was performed on clinicopathological and survival data of patients with GSC (n=31) and with RGC (n=105) following radical gastrectomy at the Chinese People's Liberation Army General Hospital between January 1992 and August 2017. GSC was defined as cancer occured in remnant stomach ≥10 years after radical gastrectomy, while RGC was defined as <10 years. Patients of both groups received radical resection or palliative operation with tumor resection and had complete clinicopathological data regarding the first operation and gastric stump operation. T-test was used to compare quantitative data between the two groups, and Pearson χ test was used to compare qualitative data between the two groups. Kaplan-Meier method was applied to draw survival curves and log-rank test to assess survival differences.
Of the 136 enrolled patients, 113 were male and 23 were female. In the first operation, compared with RGC group, in GSC group, the Borrmann type and histological differentiation were more better [Borrmann I(: 11/31 (35.5%) vs. 5/105 (4.8%), χ=23.003, P=0.001; the high differentiation: 15/31 (48.4%) vs. 1/105 (1.0%), χ=57.137, P=0.001]; the tumor diameter was smaller [<4 cm: 28/31(90.3%) vs. 56/105(53.3%), χ=14.045, P=0.001]; the pT stage [pT1: 12/31 (38.7%) vs. 3/105 (2.9%), χ=50.373, P=0.001], pN stage [pN0: 28/31 (90.3%) vs. 19/105 (18.1%), χ=55.722, P=0.001] and pTNM staging [I(: 26/31 (83.9%) vs. 11/105 (10.5%), χ=66.688, P=0.001] were earlier. Most of the GSC occurred at non-anastomotic sites, while the recurrence mostly occurred at anastomotic sites [51.6%(16/31) vs. 61.9%(65/105), χ=7.520, P=0.023]. Compared with RGC group, GSC group had better histological differentiation [high differentiation: 5/31 (16.1%) vs. 2/105(1.9%), χ=10.029, P=0.007]. There was more histological type change between the first and the second operation in GSC group than that in RGC group[48.4%(15/31) vs. 26.7%(28/105), χ=5.222, P=0.022]. The overall survival time of GSC group was significantly longer than that of RGC group [mean: (161.0±18.6) months vs. (50.8±27.6) months, respectively, Log-rank: 76.818, P=0.001]. The survival time after the second surgery of GSC group was longer than that of RGC group [mean: (30.7±18.4) months vs. (20.5±15.0) months, P=0.003]. In the subgroup analysis of all the 136 patients according to histological type change between the two surgeries (unchanged 93 patients, changed 43 patients), compared with unchanged group, the overall survival time of changed group was longer [mean: (99.6±56.5) months vs. (72.1±58.1) months, P=0.008].
GSC patients have better histological differentiation and earlier clinical stage of primary gastric cancer, and longer survival time compared with RGC patients. The histological type change between two operations may be used as a new factor to define GSC.
探讨并比较残胃癌(GSC)与胃癌根治术后复发癌(RGC)的临床病理特征,评估生存预后。
对1992年1月至2017年8月在中国人民解放军总医院接受胃癌根治术的GSC患者(n = 31)和RGC患者(n = 105)的临床病理及生存数据进行回顾性队列研究。GSC定义为胃癌根治术后≥10年残胃发生的癌,而RGC定义为<10年。两组患者均接受根治性切除或姑息性手术加肿瘤切除,并具有关于首次手术和残胃手术的完整临床病理数据。采用t检验比较两组间的定量数据,采用Pearson χ检验比较两组间的定性数据。应用Kaplan-Meier法绘制生存曲线,采用log-rank检验评估生存差异。
136例纳入患者中,男性113例,女性23例。在首次手术中,与RGC组相比,GSC组的Borrmann分型和组织学分化更好[Borrmann I型:1,1/31(35.5%)对5/105(4.8%),χ = 23.003,P = 0.001;高分化:15/31(48.4%)对1/105(1.0%),χ = 57.137,P = 0.001];肿瘤直径较小[<4 cm:28/31(90.3%)对56/(53.3%),χ = 14.045,P = 0.001];pT分期[pT1:12/31(38.7%)对3/105(2.9%),χ = 50.373,P = 0.001]、pN分期[pN0:28/31(90.3%)对19/105(18.1%),χ = 55.722,P = 0.001]和pTNM分期[I期:26/31(83.9%)对11/105(10.5%),χ = 66.688,P = 0.001]更早。大多数GSC发生在非吻合口部位,而复发大多发生在吻合口部位[51.6%(16/31)对61.9%(65/105),χ = 7.520,P = 0.023]。与RGC组相比,GSC组组织学分化更好[高分化:5/31(16.1%)对2/105(1.9%),χ = 10.029,P = 0.007]。GSC组首次与第二次手术之间的组织学类型变化比RGC组更多[48.4%(15/31)对26.7%(28/105),χ = 5.222,P = 0.022]。GSC组的总生存时间明显长于RGC组[平均:分别为(161.0±18.6)个月对(50.8±27.6)个月,Log-rank:76.818,P = 0.001]。GSC组第二次手术后的生存时间长于RGC组[平均:(30.7±18.4)个月对(20.5±15.0)个月,P = 0.003]。在根据两次手术之间的组织学类型变化对所有136例患者进行的亚组分析中(未改变93例,改变43例),与未改变组相比,改变组的总生存时间更长[平均:(99.6±56.5)个月对(72.1±58.1)个月,P = 0.008]。
与RGC患者相比,GSC患者组织学分化更好,原发性胃癌临床分期更早,生存时间更长。两次手术之间的组织学类型变化可作为定义GSC的新因素。